Диссертация (Влияние дистантного ишемического прекондиционирования и интервальных гипокси-гипероксических тренировок на течение операции и послеоперационный период при шунтировании коронарных артерий), страница 14

J Anesth. 2002;16:150–159. doi: 10.1007/s005400200011.46 Hirota K, Semenza GL. Regulation of hypoxia-inducible factor 1 by prolyl andasparaginyl hydroxylases. Biochem Biophys Res Commun. 2005;338:610–616. doi:10.1016/j.bbrc.2005.08.193.47 Maxwell PH, et al. The tumour suppressor protein VHL targets hypoxia-induciblefactors for oxygen-dependent proteolysis. Nature. 1999;399:271–275. doi:10.1038/2045948 Aragones J, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxiatolerance by reprogramming basal metabolism.

Nat Genet. 2008;40:170–180. doi:10.1038/ng.2007.62.49 Zhao T, et al. HIF-1-mediated metabolic reprogramming reduces ROS levels andfacilitates the metastatic colonization of cancers in lungs. Sci Rep. 2014;4:3793. doi:10.1038/srep0379350 Khan M., Basye A., Chen Ch.-A. et al. Intermittent Hypoxic/Hyperoxic CyclingImproves Survival of Human Inducible Pluripotent-Derived CardiomyocytesSubjected to Prolonged Hypoxia. Circulation 2014;130:A168.8251 Сазонтова Т.Г., Глазачев О.С., Болотова А.В. и др. Адаптация к гипоксии игипероксии повышает физическую выносливость: роль активных формкислорода и редокс-сигнализации.

Российский физиологический журнал им.И.М. Сеченова 2012; 98, № 6:793-80752 Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosisinduced by temporary occlusion of a coronary artery in the dog. ArchPathol. 1960;70:68–7846.53 Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword. J ClinInvest 1985;76:1713-171954 Yellon DM, Hausenloy DJ.

Myocardial reperfusion injury. N Engl J Med.2007;375:1121-113555 Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health anddisease. Physiol Rev. 2007;87:315–424.56 Raedschelders K, Ansley DM, Chen DDY. The cellular and molecular origin ofreactive oxygen species generation during myocardial ischemia andreperfusion. Pharmacol Therap. 2012;133:230–25557 Theodore Kalogeris, Christopher P.

Baines, Maike Krenz, Ronald J. Korthuis.Ischemia/Reperfusion. Compr Physiol. 2016 Dec 6; 7(1): 113–170.doi: 10.1002/cphy.c16000658 Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanismsof endothelial hyperpermeability: Implications in inflammation. Expert Rev MolMed. 2009;11:e19.59 Kvietys PR, Granger DN.

Role of reactive oxygen and nitrogen species in thevascular responses to inflammation. Free Radic Biol Med. 2012;52:556–59260 Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethalmyocardial reperfusion injury. Cardiovasc Res 2004;61:481-497.61 Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis1998;40:477-516.62 Kloner RA and Jennings RB. Consequences of brief ischemia: stunning,preconditioning and their clinical implications.

Part 1. Circ 2001;104:2981-298963 Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regionalmyocardial functional and electrophysiological alterations after brief coronary arteryocclusion in conscious dogs. J Clin Invest 1975;56:978-98564 Heyndrickx GR, Vatner SF in Kloner RA and Przyklenk K, Stunned myocardium,properties, mechanisms and clinical manifestations, Marcel Dekker Inc. New York.1993:chapter 1:3-1565 Murphy E, Eisner DA. Regulation of intracellular and mitochondrial sodium inhealth and disease. Circ Res 2009; 104: 292-3038366 J. Szepesi, K.

Acsai, Z. Sebok, J. Prorok, P. Pollesello, J. Levijoki, J.Gy. Papp, A.Varro, A. Toth. Comparison of the efficiency of Na+ /Ca2+ exchanger or Na+ /H+exchanger inhibition and their combination in reducing coronary reperfusion-inducedarrhythmias. Journal of Physiology and Pharmacology 2015, 66, 2, 215-22667 Mathew, J.P., Fontes, M.L., Tudor, I.C. et al. A multicenter risk index for atrialfibrillation after cardiac surgery. JAMA. 2004; 291: 1720–172968 Coetzee JF, Glen JB, Wium CA, Boshoff L. Pharmacokinetics model selection fortarget controlled infusions of propofol.

Assessment of three parametersets. Anesthesiology. 1995;82((6)):1328–4569 Ko SH, Yu CW, Lee SK, Choe H, Chung MJ, Kwak YG, et al. Propofol attenuatesischemia-reperfusion injury in the isolated rat heart. Anesth Analg. 1997;85:719–24.70 Roberts FL, Dixon J, Lewis GT, Tackley RM, Prys-Roberts C. Induction andmaintenanceofpropofolanaesthesia.Amanualinfusionscheme. Anaesthesia. 1988;43(Suppl):14–771 Kersten JR, Schmeling TJ, Hettrick DA, et al.

Mechanism of myocardialprotection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP)channels. Anesthesiology. 1996; 85(4): 794–807.72 Lango R, Mroziński P. Clinical importance of anaesthetic preconditioning.Anestezjol Intens Ter.

2010; 42(4): 206–212.73 De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective propertiesof sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypassare related to the modalities of its administration. Anesthesiology. 2004; 101(2): 299–31074 Zangrillo A, Musu M, Greco T, et al. Anaesthetic drugs and survival: a Bayesiannetwork metaanalysis of randomized trials in cardiac surgery. Br J Anaesth.

2013;111(6): 886–896, doi: 10.1093/bja/aet231.75 Uhlig C, Bluth T, Schwarz K, et al. Effects of volatile anesthetics on mortality andpostoperative pulmonary and other complications in patients undergoing surgery: asystematic review and metaanalysis. Anesthesiology. 2016; 124(6): 1230–1245, doi:10.1097/ALN.000000000000112076 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay oflethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–113677 Schott R.J., Rohmann S., Braun E.R., Schaper W.

Ischemic preconditioningreduces infarct size in swine myocardium. Circ Res. 1990;66(4):1133-42.78 Schott R.J., Schaper W. Ischemic preconditioning and myocardial stunning:related consequences of brief coronary occlusion and reperfusion? Adv Cardiol.1990;37:32-41.79 Li G.C., Vasquez J.A., Gallagher K.P., Lucchesi B.R. Myocardial protectionwith preconditioning. Circulation. 1990;82(2):609-198480 Przyklenk K., Bauer B., Ovize M. et al. Regional ischemic ‘preconditioning’protects remote virgin myocardium from subsequent sustained coronary occlusion.Circulation 1993; 87:893-899.81 Kharbanda R.K., Mortensen U.M., White P.A.

et al. Transient limb ischemiainduces remote ischemic preconditioning in vivo. Circulation 2002; 106:2881-288382 Серебровская Т.В., Шатило В.Б. Опыт использования интервальнойгипоксии для предупреждения и лечения заболеваний сердечно-сосудистойсистемы. Обзор. Кровообращение и гемостаз. 2014; 1-2: 16-3383 Newman M.F., Ferguson T.B., White J.A., et al. Effect of adenosine-regulatingagent acadesine on morbidity and mortality associated with coronary arterybypass grafting: the RED-CABG randomized controlled trial. JAMA. 2012 Jul11;308(2):157-64.

doi: 10.1001/jama.2012.7633.84 Belhomme D, Peynet J, Florens E, Tibourtine O, Kitakaze M, Menasché P.Is adenosine preconditioningtrulycardioprotectivein coronaryarterybypass surgery? Ann Thorac Surg. 2000 Aug;70(2):590-4.85 Blanc P, Aouifi A, Bouvier H, et al. Safety of oral nicorandil before coronaryartery bypass graft surgery. Br J Anaesth. 2001 Dec;87(6):848-5486 Ettinger G, MacDonald K, Reid G, Burton JP. The influence of the humanmicrobiome and probiotics on cardiovascular Health. Gut Microbes. 2014;5:719–728.87 Fagundes CT, Amaral FA, Teixeira AL, Souza DG, Teixeira MM.

Adapting toenvironmental stresses: The role of the microbiota in controlling innate immunity andbehavioral responses. Immunol Rev. 2012;245:250–264.88 Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, FinlayBB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing Thelper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337–34989 Yoshiya K, Lapchak PH, Thai TH, Kannan L, Rani P, Lucca JJ, Tsokos GC.Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusioninjury. Am J Physiol Gastrointest Liver Physiol.

2011;301:G1020–G103090 Prakash A, Sundar SV, Zhu YG, Tran A, Lee JW, Lowell C, Hellman J. Lungischemia-reperfusion is a sterile inflammatory process influenced by commensalmicrobiota in mice. Shock. 2015;44:272–27991 Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, SalzmanNH, Baker JE. Intestinal microbiota determine severity of myocardial infarction inrats.

FASEB J. 2012;26:1727–173592 Bliss TM, Kelly S, Shah AK, Foo WC, Kohli P, Stokes C, Sun GH, Ma M, MaselJ, Kleppner SR, Schallert T, Palmer T, Steinberg GK. Transplantation of hNTneurons into the ischemic cortex: Cell survival and effect on sensorimotor behavior. JNeurosci Res. 2006;83:1004–1014.8593 Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKayR, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerateinfarcted myocardium.

Nature. 2001;410:701–705.94 Zhang Z, Liang D, Gao X, Zhao C, Qin X, Xu Y, Su T, Sun D, Li W, Wang H,Liu B, Cao F. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks)enhances mesenchymal stem cell engraftment and improves therapeutic efficacy formyocardial infarction. Basic Res Cardiol. 2014;109:41795 Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC.Haematopoietic stem cells adopt mature haematopoietic fates in ischaemicmyocardium.

Nature. 2004;428:668–673.96 Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M,Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, WilliamsDA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiacmyocytes in myocardial infarcts. Nature. 2004;428:664–66897 Glancy B, Hartnell LM, Malide D, Yu ZX, Combs CA, Connelly PS,Subramaniam S, Balaban RS.